108 related articles for article (PubMed ID: 18776535)
1. Ribonucleosides bearing Michael acceptors: synthesis, molecular docking, enzyme inhibition data and antiviral activity.
Nair V; Uchil V; Ma X; Zhu Q; Zhang F; Bonsu E
Nucleic Acids Symp Ser (Oxf); 2008; (52):625-6. PubMed ID: 18776535
[No Abstract] [Full Text] [Related]
2. IMPDH as a biological probe for RNA antiviral drug discovery: synthesis, enzymology, molecular docking, and antiviral activity of new ribonucleosides with surrogate bases.
Nair V; Ma X; Shu Q; Zhang F; Uchil V; Cherukupalli GR
Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):651-4. PubMed ID: 18066873
[TBL] [Abstract][Full Text] [Related]
3. Base-functionalized carbocyclic nucleosides: design, synthesis, and mechanism of antiviral activity.
Nair V; Zhang F; Ma X; Bonsu E
Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):408-23. PubMed ID: 20183592
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiviral evaluation of isatin ribonucleosides.
de Oliveira MR; Torres JC; Garden SJ; dos Santos CV; Alves TR; Pinto AC; Pereira Hde S; Ferreira LR; Moussatché N; Frugulhetti IC; Ferreira VF; de Souza MC
Nucleosides Nucleotides Nucleic Acids; 2002; 21(11-12):825-35. PubMed ID: 12537024
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antiviral evaluation of beta-D- and beta-L-pentofuranonucleoside derivatives bearing 5-trifluoromethylcytosine as the base.
Marchand A; Mathé C; Gosselin G
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):861-3. PubMed ID: 14565297
[TBL] [Abstract][Full Text] [Related]
6. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
7. 2'-Deoxy-2'-C-trifluoromethyl beta-D-ribonucleoside analogues: synthesis and antiviral evaluations.
Jeannot F; Gosselin G; Mathé C
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):857-9. PubMed ID: 14565296
[TBL] [Abstract][Full Text] [Related]
8. IMP dehydrogenase as a target of antitumor and antiviral chemotherapy.
Franchetti P; Cappellacci L; Grifantini M
Farmaco; 1996 Jul; 51(7):457-69. PubMed ID: 8765668
[No Abstract] [Full Text] [Related]
9. Cytostatic and antiviral 6-arylpurine ribonucleosides. Part 7: synthesis and evaluation of 6-substituted purine l-ribonucleosides.
Hocek M; Silhár P; Shih IH; Mabery E; Mackman R
Bioorg Med Chem Lett; 2006 Oct; 16(20):5290-3. PubMed ID: 16905315
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of inosine monophosphate dehydrogenase: probes for antiviral drug discovery.
Story S; Gupta M; Bonsu E; Nair V
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):717-20. PubMed ID: 16248022
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activities of 2-functionalized purine nucleosides.
Nair V; Bera B; Kern ER
Nucleosides Nucleotides Nucleic Acids; 2003 Feb; 22(2):115-27. PubMed ID: 12744599
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral evaluation of 2'-C-methyl analogues of 5-alkynyl- and 6-alkylfurano- and pyrrolo[2,3-d]pyrimidine ribonucleosides.
Januszczyk P; Fogt J; Boryski J; Izawa K; Onishi T; Neyts J; De Clercq E
Nucleosides Nucleotides Nucleic Acids; 2009 May; 28(5):713-23. PubMed ID: 20183611
[TBL] [Abstract][Full Text] [Related]
13. Cytostatic 6-arylpurine nucleosides. 6. SAR in anti-HCV and cytostatic activity of extended series of 6-hetarylpurine ribonucleosides.
Hocek M; Naus P; Pohl R; Votruba I; Furman PA; Tharnish PM; Otto MJ
J Med Chem; 2005 Sep; 48(18):5869-73. PubMed ID: 16134952
[TBL] [Abstract][Full Text] [Related]
14. Ribose-modified mizoribine analogues: synthesis and biological evaluation.
Franchetti P; Pasqualini M; Cappellacci L; Petrelli R; Vita P; Grifantini M
Nucleosides Nucleotides Nucleic Acids; 2005; 24(10-12):2023-7. PubMed ID: 16438062
[TBL] [Abstract][Full Text] [Related]
15. The predominant mechanism by which ribavirin exerts its antiviral activity in vitro against flaviviruses and paramyxoviruses is mediated by inhibition of IMP dehydrogenase.
Leyssen P; Balzarini J; De Clercq E; Neyts J
J Virol; 2005 Feb; 79(3):1943-7. PubMed ID: 15650220
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and antiviral evaluation of 2-chloro-5,6-dihalo-1-beta-D-ribofuranosylbenzimidazoles as potential agents for human cytomegalovirus infections.
Zou R; Drach JC; Townsend LB
J Med Chem; 1997 Feb; 40(5):811-8. PubMed ID: 9057868
[TBL] [Abstract][Full Text] [Related]
17. Discovery of a novel HCV helicase inhibitor by a de novo drug design approach.
Kandil S; Biondaro S; Vlachakis D; Cummins AC; Coluccia A; Berry C; Leyssen P; Neyts J; Brancale A
Bioorg Med Chem Lett; 2009 Jun; 19(11):2935-7. PubMed ID: 19414257
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structure, and antiproliferative activity of selenophenfurin, an inosine 5'-monophosphate dehydrogenase inhibitor analogue of selenazofurin.
Franchetti P; Cappellacci L; Sheikha GA; Jayaram HN; Gurudutt VV; Sint T; Schneider BP; Jones WD; Goldstein BM; Perra G; De Montis A; Loi AG; La Colla P; Grifantini M
J Med Chem; 1997 May; 40(11):1731-7. PubMed ID: 9171883
[TBL] [Abstract][Full Text] [Related]
19. Oxanosine Monophosphate Is a Covalent Inhibitor of Inosine 5'-Monophosphate Dehydrogenase.
Yu R; Kim Y; Maltseva N; Braunstein P; Joachimiak A; Hedstrom L
Chem Res Toxicol; 2019 Mar; 32(3):456-466. PubMed ID: 30746940
[TBL] [Abstract][Full Text] [Related]
20. An alternative pathway to ribonucleoside β-hydroxyphosphonate analogues and related prodrugs.
Hospital A; Meurillon M; Peyrottes S; Périgaud C
Org Lett; 2013 Sep; 15(18):4778-81. PubMed ID: 24015803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
